n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Cancer of Ovary in 14 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "VEGF may play a role in ovarian cancer progression in the hen and the proliferation of ascites cells can be decreased by targeting the COX-1 but not COX-2 pathway." | 1.35 | VEGF expression and the effect of NSAIDs on ascites cell proliferation in the hen model of ovarian cancer. ( Giles, JR; Johnson, PA; Urick, ME, 2008) |
| "Four epithelial ovarian cancer cell lines (MDAH-2774, SKOV3, OVCAR and CaOV-3) were treated with the specific cyclooxygenase-2 inhibitor NS398 (10 or 100 mumol/l) and docetaxel (0." | 1.34 | The effects of combining docetaxel and cyclooxygenase-2 inhibitors on proliferation and apoptosis in epithelial ovarian cancer. ( Ali-Fehmi, R; Elhammady, E; Jiang, JZ; Malone, JM; Munkarah, AR; Saed, GM, 2007) |
| "Apoptosis was observed in primary ovarian cancer cell culture treated with COX-2 inhibitor." | 1.31 | Effects of nonsteroidal anti-inflammatory agents (NSAIDs) on ovarian carcinoma cell lines: preclinical evaluation of NSAIDs as chemopreventive agents. ( Barnes, MN; Grizzle, WE; Myers, RB; Oelschlager, DK; Partridge, EE; Rodríguez-Burford, C; Talley, LI, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (71.43) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, X | 1 |
| Liang, Y | 1 |
| Wang, J | 1 |
| Wang, M | 2 |
| Lin, HY | 1 |
| Delmas, D | 1 |
| Vang, O | 1 |
| Hsieh, TC | 1 |
| Lin, S | 1 |
| Cheng, GY | 1 |
| Chiang, HL | 1 |
| Chen, CE | 1 |
| Tang, HY | 1 |
| Crawford, DR | 1 |
| Whang-Peng, J | 1 |
| Hwang, J | 1 |
| Liu, LF | 1 |
| Wu, JM | 1 |
| Qiu, X | 1 |
| Cheng, JC | 1 |
| Chang, HM | 1 |
| Leung, PC | 1 |
| Sonnemann, J | 1 |
| Hüls, I | 1 |
| Sigler, M | 1 |
| Palani, CD | 1 |
| Hong, le TT | 1 |
| Völker, U | 1 |
| Kroemer, HK | 1 |
| Beck, JF | 1 |
| Urick, ME | 1 |
| Giles, JR | 1 |
| Johnson, PA | 1 |
| Uddin, S | 1 |
| Ahmed, M | 1 |
| Hussain, A | 1 |
| Assad, L | 1 |
| Al-Dayel, F | 1 |
| Bavi, P | 1 |
| Al-Kuraya, KS | 1 |
| Munkarah, A | 1 |
| Munkarah, AR | 2 |
| Genhai, Z | 1 |
| Morris, R | 1 |
| Baker, VV | 1 |
| Deppe, G | 1 |
| Diamond, MP | 1 |
| Saed, GM | 2 |
| Wang, CY | 1 |
| Wang, XY | 1 |
| Zhang, SL | 1 |
| Wang, YX | 1 |
| Li, LK | 1 |
| Denkert, C | 1 |
| Fürstenberg, A | 1 |
| Daniel, PT | 1 |
| Koch, I | 1 |
| Köbel, M | 1 |
| Weichert, W | 1 |
| Siegert, A | 1 |
| Hauptmann, S | 1 |
| Spinella, F | 1 |
| Rosanò, L | 1 |
| Di Castro, V | 1 |
| Nicotra, MR | 1 |
| Natali, PG | 1 |
| Bagnato, A | 1 |
| Kang, S | 1 |
| Luo, R | 1 |
| Smicun, Y | 1 |
| Fishman, DA | 1 |
| Meng, Y | 1 |
| Barnes, AP | 1 |
| Miller, BE | 1 |
| Kucera, GL | 1 |
| Ali-Fehmi, R | 1 |
| Jiang, JZ | 1 |
| Elhammady, E | 1 |
| Malone, JM | 1 |
| Rodríguez-Burford, C | 1 |
| Barnes, MN | 1 |
| Oelschlager, DK | 1 |
| Myers, RB | 1 |
| Talley, LI | 1 |
| Partridge, EE | 1 |
| Grizzle, WE | 1 |
14 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Cancer of Ovary
| Article | Year |
|---|---|
Effect of NS-398, a cyclooxygenase-2 selective inhibitor, on the cytotoxicity of cytotoxic T lymphocytes to ovarian carcinoma cells.
Topics: Apoptosis; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cystadenocarcinoma, Se | 2013 |
Mechanisms of ceramide-induced COX-2-dependent apoptosis in human ovarian cancer OVCAR-3 cells partially overlapped with resveratrol.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Caspase 3; Caspase 7; Cell Line, Tumor; Ceramide | 2013 |
COX2 and PGE2 mediate EGF-induced E-cadherin-independent human ovarian cancer cell invasion.
Topics: Cadherins; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Down-Regul | 2014 |
Histone deacetylase inhibitors and aspirin interact synergistically to induce cell death in ovarian cancer cells.
Topics: Apoptosis; Aspirin; Cell Line, Tumor; Cyclooxygenase Inhibitors; Drug Synergism; Enzyme Inhibitors; | 2008 |
VEGF expression and the effect of NSAIDs on ascites cell proliferation in the hen model of ovarian cancer.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Ascites; Aspirin; Cell Growth Processes; Chickens; | 2008 |
Cyclooxygenase-2 inhibition inhibits PI3K/AKT kinase activity in epithelial ovarian cancer.
Topics: Animals; Apoptosis; Aspirin; Blotting, Western; Cell Line, Tumor; Cell Survival; Cyclooxygenase 2; C | 2010 |
Inhibition of paclitaxel-induced apoptosis by the specific COX-2 inhibitor, NS398, in epithelial ovarian cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aspiri | 2003 |
[Inhibitory effect of NS398 on the proliferation of human ovarian cancer cell lines CAOV3 and OVCAR3 in vitro].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Division; Cyclooxygenase Inhibitors; Female | 2003 |
Induction of G0/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Division; Cell Line, Tumor; Cell Survival; Cyclooxygen | 2003 |
Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Topics: Animals; Atrasentan; Blotting, Northern; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cy | 2004 |
Selective induction of cyclooxygenase-2 plays a role in lysophosphatidic acid regulated Fas ligand cell surface presentation.
Topics: Animals; Antigen Presentation; Antigens, Surface; Apoptosis; Aspirin; Cell Line, Tumor; Cell Membran | 2006 |
Cyclooxygenase inhibition and hyperthermia for the potentiation of the cytotoxic response in ovarian cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclooxygenase | 2007 |
The effects of combining docetaxel and cyclooxygenase-2 inhibitors on proliferation and apoptosis in epithelial ovarian cancer.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Carcinoma; Cell Cycle; Cel | 2007 |
Effects of nonsteroidal anti-inflammatory agents (NSAIDs) on ovarian carcinoma cell lines: preclinical evaluation of NSAIDs as chemopreventive agents.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Biopsy; Blotting, Wester | 2002 |